Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buparlisib Phase 3 trial (Japan)
jRCT2080221865Phase 3Completed
- Start
- Jul 2012
- Modality
- Small Molecules
01
Overview
Phase 3 trial of buparlisib in cancer. Started Jul 2012; status: completed.
02
Drugs
buparlisib
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080221865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221865.